{"nct_id":"NCT01989676","title":"A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)","status":"COMPLETED","status_verified_date":"2021-06","start_date":"2014-02-24","start_date_type":"ACTUAL","primary_completion_date":"2016-08-24","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}